PROGRAMMED CELL DEATH IN LYMPHOCYTES
PROGRAMMED CELL DEATH IN LYMPHOCYTES
批准号:
3774389
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
CD3 molecule HIV infections RNA directed DNA polymerase T cell receptor T lymphocyte antibody receptor antineoplastics apoptosis calpain cellular immunity cytolysins cytotoxic T lymphocyte cytotoxicity endopeptidases enzyme activity gene expression granule helper T lymphocyte hormone regulation /control mechanism interleukin 2 interleukin 4 laboratory rat leukocyte activation /transformation lymphocyte lymphocyte proliferation messenger RNA monoclonal antibody natural killer cells northern blottings polymerase chain reaction pore forming protein protease inhibitor protein structure function proteins proteoglycan tissue /cell culture
中文摘要
为了测试颗粒胞吐模型的淋巴细胞毒性,
我们检测了大鼠粘膜肥大细胞瘤的细胞毒活性,
细胞毒性淋巴细胞颗粒基因转染后的RBL细胞
件. 我们已经构建了三重,双重和单一的RBL
表达溶细胞素(cy)和颗粒丝氨酸蛋白酶的转染子
颗粒酶A(gza)和颗粒酶B(gz B)。 RBL-cy转染子仅显示
对肿瘤靶点的中度细胞毒性,无伴随靶DNA
降解 而RBL-gza转染子表达的gza水平与
克隆的CTL并分泌它以响应IgER交联,
未检测到细胞毒活性。RBL-cy-gza转染子克隆显示
这两种颗粒组分的良好表达显示出细胞溶解活性
与RBC靶点上的RBL-cy相当,但溶解性超过3倍
三种不同的肿瘤靶点 这种细胞毒性伴随着
靶向DNA片段化。 为了证实杀伤细胞颗粒酶需要
进入靶细胞,我们在靶细胞上装载了大分子,
蛋白酶抑制剂抑肽酶通过渗透裂解的胞饮体。 相比
BSA负载靶点或未负载靶点,抑肽酶靶点较少
易受CTL和RBL转染子裂解和DNA断裂的影响
表达颗粒酶A。 然而,RBL转染子仅表达
溶细胞素裂解BSA负载的和抑肽酶负载的靶标,
效率 作为对蛋白酶诱导细胞凋亡能力的直接测试,
当引入靶细胞的细胞质中时,
使用渗透裂解法将各种蛋白酶“注射”到肿瘤细胞中。
胞饮体 内切蛋白酶胰蛋白酶、胰凝乳蛋白酶和蛋白酶K为
所有这些都被发现在一个剂量下溶解几种不同类型的肿瘤细胞
依赖的方式,如通过51 Cr释放测量的。 这种死亡通常是
通过形态学标准和DNA片段化检测细胞凋亡。
英文摘要
In order to test the granule exocytosis model for lymphocyte cytotoxicity,
we have examined the cytotoxic activity of the rat mucosal mast cell tumor
line RBL after transfection with genes for cytotoxic lymphocyte granule
components. We have constructed triple, double, and single RBL
transfectants expressing cytolysin (cy) and the granule serine proteases
granzyme A (gza) and granzyme B (gzb). RBL-cy transfectants show only
modest cytotoxicity on tumor targets, with no accompanying target DNA
degradation. While RBL-gza transfectants express gza at levels comparable
to cloned CTL and secrete it in response to IgER cross-linking, they have
no cytotoxic activity detectable. RBL-cy-gza transfectant clones showing
good expression of both these granule components showed cytolytic activity
comparable to RBL-cy on RBC targets, but were greater than 3x more lytic
on three different tumor targets. This cytotoxicity is accompanied by
target DNA fragmentation. To confirm that killer cell granzymes need to
enter the target cell, we loaded target cells with the macromolecular
protease inhibitor aprotinin by osmotic lysis of pinosomes. Compared to
BSA-loaded targets or unloaded targets, aprotinin-targets were less
susceptible to lysis and DNA breakdown by CTL and RBL transfectants
expressing granzyme A. However, RBL transfectants expressing only
cytolysin lysed BSA-loaded and aprotinin-loaded targets with equal
efficiency. As a direct test of the ability of proteases to induce
cytotoxicity when introduced into the cytoplasm of a target cell, we have
"injected" various proteases into tumor cells using osmotic lysis of
pinosomes. The endoproteases trypsin, chymotrypsin, and proteinase K were
all found to lyse several different types of tumor cells in a dose
dependent manner, as measured by 51Cr release. This death was generally
apoptotic by morphological criteria and DNA fragmentation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3774385
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3752088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
海外基金